Transient Oculomotor Palsy Following the Administration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following the COVID-19 Vaccine

J Neuroophthalmol. 2023 Mar 1;43(1):e14-e15. doi: 10.1097/WNO.0000000000001369. Epub 2021 Aug 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Diplopia / etiology
  • Humans
  • Paralysis
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines